These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 16780770)

  • 1. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
    Liang GW; Lu WL; Wu JW; Zhao JH; Hong HY; Long C; Li T; Zhang YT; Zhang H; Wang JC; Zhang X; Zhang Q
    Fundam Clin Pharmacol; 2008 Aug; 22(4):429-37. PubMed ID: 18705753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) greatly enhance the responses of multidrug-resistant K562 leukemic cells in a nude mouse xenograft model to chemotherapy.
    Lai BB; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):345-51. PubMed ID: 19379564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
    Jin J; Wang FP; Wei H; Liu G
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
    Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
    Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
    Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment of K562 cell lines resistant to STI571 and a preliminary biological study].
    Gao L; Wang JM; Xu XP; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):584-9. PubMed ID: 15498115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo acquired drug resistance and multidrug resistance gene (MDR1) expression in the KB carcinoma cell line xenotransplanted in nude mice.
    Abe Y; Nakamura M; Saegusa R; Ueyama Y; Ogata T; Tamaoki N
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):99-106. PubMed ID: 7701536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL-2 antisense oligonucleotide genasense is active against imatinib-resistant BCR-ABL-positive cells.
    Tauchi T; Sumi M; Nakajima A; Sashida G; Shimamoto T; Ohyashiki K
    Clin Cancer Res; 2003 Sep; 9(11):4267-73. PubMed ID: 14519654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spectrum of gene expression of a multi-drug resistant leukemia cell line with high tumorigenicity in nude mice].
    Chen L; Xu XP; Wang JM; Li Y; Xu H; Lü SQ; Fei XH; Huang ZX
    Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):196-200. PubMed ID: 15949414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of high expression of HSP27 to multidrug resistance of leukemia cell line K562/VCR].
    Zhang ZX; Wen FQ; Liu ZP; Cheng YD
    Ai Zheng; 2008 Apr; 27(4):348-53. PubMed ID: 18423118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
    Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
    J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells.
    Mukai M; Che XF; Furukawa T; Sumizawa T; Aoki S; Ren XQ; Haraguchi M; Sugimoto Y; Kobayashi M; Takamatsu H; Akiyama S
    Cancer Sci; 2003 Jun; 94(6):557-63. PubMed ID: 12824882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.